JPRN-UMIN000005837已完成未知
Effects of calcium channel blockers on glucose tolerance and endothelial function in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on Glucose tolerance and Endothelial functioN - a crossover Trial (AGENT) - AGENT
Juntendo University School of Medicine, Department of Cardiovascular Medicine0 个研究点目标入组 18 人开始时间: 2011年6月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with history of allergy for the study drugs 2. Patients with history of cardiovascular disorders within 3 months 3. Patients with diabetes 4. Patients with serum creatinine >= 2.0mg/dl 5. Patients with systemic diseases 6. Patients with history of gastrointestinal surgery 7. Patients who are judged inappropriate for entry into this study by the investigator
研究者
相似试验
招募中
不适用
Effects of an Inhibitor of Sodium-glucose Cotransporter 2 for Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease (NAFLD).Patients of type 2 diabetes mellitus with nonalcoholic fatty liver disease (NAFLD).JPRN-UMIN000020615Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine.20
进行中（未招募）
不适用
Evaluation of potential central glucoregulatory compounds to treat/ameliorate the symptoms of schizophrenia: a proof-of-concept study in healthy volunteers - EICASBasic ressearch on schizophrenia. This is a proof-of-concept trial. The hypothesis is that substances that regulate the central glucose utilisation might ameliorate symptoms of schizophrenic psychosis. In this clinical trial healthy volunteers will take one of these substances or placebo for seven days and will extensively tested for within and after the administration.MedDRA version: 9.1Level: LLTClassification code 10039626Term: SchizophreniaEUCTR2007-002245-20-DEZentralinstitut für Seelische Gesundheit Mannheim
已完成
不适用
Calcium supplementation on blood glucose, lipids and obesity in Chinese womeObesity, blood glucose and lipidsNutritional, Metabolic, EndocrineOther nutritional deficienciesISRCTN74325268Harbin Medical University (China)400
进行中（未招募）
1 期
SOdium-glucose CO-transporter inhibition in patients with Type 2 Diabetes and Ischemic Heart FailurePatients with type 2 diabetes mellitus and heart failure of ischemic originEUCTR2015-005715-32-SEKarolinska Institutet Stockholm, Sweden60
已完成
不适用
Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000018367Ise Red Cross Hospital Department of Metabolic Diseases30